News
Postoperative nivolumab added to standard-of-care adjuvant cisplatin radiotherapy “represents a potential new standard.” ...
Additional data presented at ASCO highlights Libtayo’s ability to hold off recurrence of a type of skin cancer.
Following Merus’ splash last month with a “best-in-disease profile” for its head and neck cancer bispecific, Bicara touted ...
22h
News-Medical.Net on MSNCombination treatment extends progression-free survival in advanced skin cancerIn patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the ...
Drugs that boost the body’s immune system to fight disease are showing promise in treating a variety of cancers in earlier ...
11h
Health and Me on MSNCOVID-19 Cases In India Continue To Surge, Kerala Tops The ListCOVID-19 cases in India rise to 3,758, with Kerala leading at 1,400. New infections and deaths reported across states, ...
20hon MSN
The Ministry of Health and Family Welfare (MoHFW) reported 363 new cases in the past 24 hours, according to data released on Sunday, 1 June.
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation (NEC; TSE: 6701), a leader in IT, network and ...
21h
News-Medical.Net on MSNAvelumab and cetuximab combination shows promise in phase II skin cancer trialA phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...
13hon MSN
Covid-19: 360 new cases were reported in 24 hrs; active cases rose to 3,758, with Kerala at 1,400 and Maharashtra at 506 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results